Treatment of chronic total venous occlusions in patients with end stage renal disease

Journal of Nephrology & Therapeutics

ISSN: 2161-0959

Open Access

Treatment of chronic total venous occlusions in patients with end stage renal disease

12th Global Nephrologists Annual Meeting

June 26-28, 2017 London, UK

Edwin Rodriguez-Cruz

San Jorge Children's Hospital, USA
San Juan Bautista School of Medicine, USA

Scientific Tracks Abstracts: J Nephrol Ther

Abstract :

Chronic Total Venous Occlusions (CTVO) are one of the many challenges physicians have to confront in the daily treatment of patients with End Stage Renal Disease (ESRD). Even in cases where an arteriovenous fistula is present, central venous occlusions may occur and be a hassle for the culmination of therapy by hemodialysis. A total of 79 patients with CTVO has undergone reopening of the vessels in our institution, of those 29 had ESRD. The 29 patients comprised: 17 females and 12 males. The mean age was 17 years (8- 76 years). One female patient was lost to follow up. The time at presentation was a mean of 4 months (3-9 months). The majority of patients had swelling of one extremity or face, and difficulty with dialysis upon presentation. A total of 48 percutaneous interventions were carried out. In all the patients, we were able to open the anomalous vessel. Twelve (12) patients required more than 1 intervention to maintain patency of their diseased vessel. The shortest time to need another procedure was 1 month, and the longest 25 months. Stents were implanted in 11 patients with 2 requiring more than 1 stent in different occasions. Of the patients with only 1 procedure, the range without re-interventions is from 1 month to 5 years. The most commonly intervened vessels were central thoracic veins. With the application of simple methods of reopening the CTVO percutaneously, we have achieved a good medium term patency in patients with ESRD. With newer technologies however, possibly adapted from arterial interventions, the longevity of these accesses may be prolonged.

Biography :

Edwin Rodriguez-Cruz has completed Doctorate degree from the San Juan Bautista School of Medicine, PR. He specializes in Internal Medicine & Pediatrics. He completed Pediatric Cardiology fellowship and sub-fellowship in Interventional Cardiology from the Children's Hospital of Michigan. Currently, he is the Director of Cardiology of the San Jorge Children's Hospital, and Associate Professor of Medicine and Pediatrics at the San Juan Bautista School of Medicine, PR, USA. He has published over 20 articles in peer review journals and many specialty opinions by editors' request. His interests are in the areas of heart failure, structural heart diseases, and difficult venous accesses. He has special interest in chronic total venous occlusions (CTVO).


Google Scholar citation report
Citations: 784

Journal of Nephrology & Therapeutics received 784 citations as per Google Scholar report

Journal of Nephrology & Therapeutics peer review process verified at publons

Indexed In

arrow_upward arrow_upward